Search hospitals > Louisiana > Marrero

Tandem Clinical Research

Claim this profile
Marrero, Louisiana 70072
Global Leader in Non-alcoholic Fatty Liver Disease
Global Leader in Fatty Liver Disease
Conducts research for Liver Disease
Conducts research for Liver Cirrhosis
Conducts research for Obesity
99 reported clinical trials
4 medical researchers
Photo of Tandem Clinical Research in MarreroPhoto of Tandem Clinical Research in MarreroPhoto of Tandem Clinical Research in Marrero

Summary

Tandem Clinical Research is a medical facility located in Marrero, Louisiana. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Liver Disease, Liver Cirrhosis, Obesity and other specialties. Tandem Clinical Research is involved with conducting 99 clinical trials across 92 conditions. There are 4 research doctors associated with this hospital, such as Gary Reiss, MD, Adil Fatakia, MD, Lincoln Hernandez, MD, and Angela Traylor, MD.

Area of expertise

1Non-alcoholic Fatty Liver Disease
Global Leader
Tandem Clinical Research has run 25 trials for Non-alcoholic Fatty Liver Disease. Some of their research focus areas include:
Stage I
Stage II
2Fatty Liver Disease
Global Leader
Tandem Clinical Research has run 24 trials for Fatty Liver Disease. Some of their research focus areas include:
Stage I
Stage II

Top PIs

Clinical Trials running at Tandem Clinical Research

Non-alcoholic Fatty Liver Disease
Type 2 Diabetes
Crohn's Disease
Fatty Liver Disease
Ulcerative Colitis
Osteoarthritis
Depression
Diabetes
Pathologic Constriction
Major Depressive Disorder
Image of trial facility.

Resmetirom

for Fatty Liver Disease

This study is evaluating whether a drug may help treat nonalcoholic steatohepatitis (NASH).
Recruiting1 award Phase 36 criteria
Image of trial facility.

Lanifibranor

for Nonalcoholic Steatohepatitis (NASH)

This study is evaluating whether a drug called lanifibranor can improve liver health in people with nonalcoholic steatohepatitis.
Recruiting1 award Phase 31 criteria
Image of trial facility.

ALN-HSD

for NASH with Fibrosis

This study is researching an investigational drug called ALN-HSD (called "study drug"). This study is focused on participants who are known to have non-alcoholic steatohepatitis (NASH). NASH is a form of non-alcoholic fatty liver disease (NAFLD). Recently, the name metabolic dysfunction associated steatohepatitis (MASH) has been introduced to replace NASH and metabolic dysfunction-associated steatotic liver disease (MASLD) to replace NAFLD. NASH occurs when fat builds up in liver cells, damaging them, and making the liver inflamed and stiff from fibrosis (scar tissue). NASH can progress to cirrhosis (long term scarring) and liver failure (when the liver cannot perform its job). The aim of the study is to see the effect of the study drug on lessening liver scarring side effects related to NASH. The study is looking at several other research questions, including: How the study drug works to improve liver function and lessen NASH related inflammation in the liver What side effects may happen from receiving the study drug How much study drug and study drug metabolites (byproduct of the body breaking down the study drug) are in the blood at different times Better understanding of the study drug and NASH
Recruiting0 awards Phase 22 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Tandem Clinical Research?
Tandem Clinical Research is a medical facility located in Marrero, Louisiana. This center is recognized for care of Non-alcoholic Fatty Liver Disease, Fatty Liver Disease, Liver Disease, Liver Cirrhosis, Obesity and other specialties. Tandem Clinical Research is involved with conducting 99 clinical trials across 92 conditions. There are 4 research doctors associated with this hospital, such as Gary Reiss, MD, Adil Fatakia, MD, Lincoln Hernandez, MD, and Angela Traylor, MD.